Compared with stroke-vehicle control mice, the levels of pro-angiogenic factors VEGF, EPOR, Tie-1 and the neurotrophin BDNF significantly increased in PTH treated mice (n = 3 in stroke and stroke plus PTH groups, respectively; P<0.05) (Fig. 2). The gene discussed is PTH; the disease is stroke disorder.